The systematic review implemented by our study group did not find any evidence that cancer surveillance would improve the prognosis of individuals with TP53 pathogenic variant, but the cancer detection rate of cancer surveillance is high, and detected cancers often did not have metastasis. Here, TP53 is linked to cancer.